A pre-clinical murine model of oral implant osseointegration  by Mouraret, S. et al.
Bone 58 (2014) 177–184
Contents lists available at ScienceDirect
Bone
j ourna l homepage: www.e lsev ie r .com/ locate /boneOriginal Full Length Article
A pre-clinical murine model of oral implant osseointegration
S. Mouraret a,b, D.J. Hunter a, C. Bardet a,c, J.B. Brunski a, P. Bouchard b, J.A. Helms a,⁎
a Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford School of Medicine, Stanford, CA 94305, USA
b Department of Periodontology, Service of Odontology, Rothschild Hospital, AP-HP, Paris 7 Denis, Diderot University, U.F.R. of Odontology, Paris, France
c Dental School University Paris Descartes PRES Sorbonne Paris Cité, EA 2496 Montrouge, France⁎ Corresponding author. Fax: +1 650 736 4374.
E-mail address: jhelms@stanford.edu (J.A. Helms).
8756-3282 © 2013 The Authors. Published by Elsevier In
http://dx.doi.org/10.1016/j.bone.2013.07.021a b s t r a c ta r t i c l e i n f oArticle history:
Received 23 November 2012
Revised 31 May 2013
Accepted 10 July 2013
Available online 23 July 2013







ModelMany of our assumptions concerning oral implant osseointegration are extrapolated from experimental models
studying skeletal tissue repair in long bones. This disconnect between clinical practice and experimental research
hampers our understanding of bone formation around oral implants and how this process can be improved. We
postulated that oral implant osseointegration would be fundamentally equivalent to implant osseointegration
elsewhere in the body. Mice underwent implant placement in the edentulous ridge anterior to the ﬁrst molar
and peri-implant tissues were evaluated at various timepoints after surgery.
Our hypothesiswasdisproven; oral implant osseointegration is substantially different fromosseointegration in long
bones. For example, in themaxilla peri-implant pre-osteoblasts are derived from cranial neural crestwhereas in the
tibia peri-implant osteoblasts are derived frommesoderm. In the maxilla, new osteoid arises from periostea of the
maxillary bone but in the tibia the new osteoid arises from the marrow space. Cellular and molecular analyses in-
dicate that osteoblast activity andmineralization proceeds from the surfaces of the native bone and osteoclastic ac-
tivity is responsible for extensive remodeling of the new peri-implant bone. In addition to histologic features of
implant osseointegration, molecular and cellular assays conducted in a murine model provide new insights into
the sequelae of implant placement and the process by which bone is generated around implants.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Oral implants are considered to be very successful prosthetic de-
vices. They successfully replace the function of teeth and restore es-
thetics, and do so with a remarkably low failure/complication rate.
Given these appealing characteristics, it is understandable that over
the last decade the demand for oral implants has risen sharply [1].
With this precipitous increase has come a staggering array of implant
modiﬁcations, all designed to improve the process of osseointegration.
These modiﬁcations include adjustments in the time to loading [2], var-
iations in surface characteristics [3], alterations in implant shape [4], and
the addition of growth factors or other biological stimuli intended to
“activate” the implant surface [5]. The extent to which most of these
modiﬁcations actually improve implant osseointegration, however, is
not known. Clearly, understanding the beneﬁts and detriments of
these changes is critically important if wewant tomaintain the success-
ful proﬁle of oral implants.
Consequently, it comes as somewhat of a surprise that the vast ma-
jority of experimental studies on oral implant osseointegration are
conducted in long bones, rather than on the maxilla or mandible. Thec. Open access under CC BY-NC-ND limost often-quoted reasons for carrying out analyses of oral implants
in long bones are their relative size and easy accessibility [6–8]. Long
bones also contain a very large and pro-osteogenic marrow cavity,
which facilitates rapid bone formation around an implant [9,10].
Furthermore, studies that we conducted in mice demonstrate that the
marrow space is primarily responsible for generating this new peri-
implant bone [6,10,11]. Using an in vivo loading device, we further
demonstrated that deﬁned forces delivered to the implant in the tibia
in turn produce measurable deformations [12]. Using this information
we have identiﬁed principal strains in the 10–20% range to stimulate
osseointegration [13,14]. Genetic mouse models have been particularly
helpful in identifying key variables that inﬂuence osseointegration;
namely, we demonstrated that early excessive micromotion can cause
ﬁbrous encapsulation [15] and the elimination ofmechanically sensitive
cellular appendages such as primary cilia can obliterate the strain-
induced bone formation [16,17].
All of these studies have been conducted in the tibia. The vastmajor-
ity of implants are placed in the oral cavity [18] but in experimental
models the oral cavity represents a novel, nearly unexplored, andpartic-
ularly challenging microenvironment for implant osseointegration. In-
vestigators have reported on the use of rat models to study oral
implant osseointegration [19,20], some with considerable success [21].
Here, we sought to extend theseﬁndings using ananimalmodel amena-
ble to genetic manipulation. Our goal was to recapitulate this unique
milieu of implant osseointegration in the oral cavity using a mouse
model, where a vast armamentarium of genetic models and molecularcense.
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improve the process of osseointegration.
Materials and methods
Animal care
All procedures followed protocols approved by the Stanford Commit-
tee on Animal Research. Wild type, male, skeletally mature (between 3
and 5 months old) CD1 mice that had an average weight of 28 g were
obtained from the Jackson Laboratory (Bar Harbor, ME). Animals were
housed in a temperature-controlled environment with 12-h light dark
cycles and were given soft diet food (Bio Serv product #S3472) and
water ad libitum. No antibiotics were given to the operated animals
and there was no evidence of infection or prolonged inﬂammation at
any of the surgical sites.
Implant surgery in the oral cavity
Twenty-three adult mice were anesthetized with an intraperitoneal
injection of Ketamine (80 mg/kg) and Xylazine (16 mg/kg). The mouth
was rinsed using a povidone–iodine solution for 1 min followed by a
sulcular incision (Micro angled blade 10035-15, Fine Science Tools,
USA) that extended from the maxillary ﬁrst molar to the mid-point on
the alveolar crest until behind the incisor. A full-thickness ﬂap was ele-
vated; a pilot hole was made to prepare the implant bed on the crest,
1.5 mm in front of the ﬁrst maxillary molar using a Ø 0.3 mm pilot
drill bit (Drill Bit City, Chicago, IL), and followed with a drill bit of Ø
0.45 mm. All drill holes were made using a low-speed dental engine
(800 rpm). In cases where no implants were placed, the surgical site
was carefully rinsed and closed using non-absorbable single interrupted
sutures (Ethilon Monoﬁlament 9-0, BV100-3, 5 in., Johnson & Johnson
Medical, USA).
In cases where an implant was placed, the titanium implant
(0.6 mm diameter titanium-6 aluminum-4 vanadium alloy “Retopins”,
NTI KahlaGmbH, Germany)was cut at length of 2 mmandwas screwed
down in the implant bed, maintained by a needle holder. A small por-
tion of the implant was left exposed, approximating the height of the
gingiva following with the standard procedure used for one-step oral
implant placement. The ﬂap was closed as described above. Following
surgery, clinical examinations were performed and mice received sub-
cutaneous injections of buprenorphine (0.05–0.1 mg/kg) for analgesia
once a day for 3 days. Mice were sacriﬁced at 7, 14, 21 and 28 days
post-surgery.
Implant surgery in the tibia
Adult wild-type mice were anesthetized as above; an incision was
made over the right anterior-proximal tibia surface. Care was taken to
preserve the periosteal surface. Holes were drilled through one cortex
using a 1 mm drill bit (Drill Bit City, Chicago, IL). Implants were placed
as described [12,14]. The skin was closed around the implant with non-
absorbable sutures as described above, and pain management was
followed as described above.
Sample preparation, processing, histology
Maxillae and tibias were harvested, the skin and outer layers of mus-
cle were removed, and the tissues were ﬁxed in 4% paraformaldehyde
overnight at 4 °C. Samples were decalciﬁed in a heat-controlled micro-
wave in 19% EDTA for two weeks and after complete demineralization,
the implant was gently removed from the samples. Specimens were
dehydrated through an ascending ethanol series prior to parafﬁn embed-
ding. Eight-micron-thick longitudinal sections were cut and collected on
SuperFrost-plus slides for histology including Movat's pentachrome, an-
iline blue, and Picrosirius red staining.Cellular assays
Alkaline phosphatase (ALP) activity was detected by incubation in
nitro blue tetrazolium chloride (NBT; Roche), 5-bromo-4-chloro-3-
indolyl phosphate (BCIP; Roche), and NTM buffer (100 mM NaCl,
100 mM Tris pH 9.5, 5 mM MgCl). Tartrate-resistant acid phosphatase
(TRAP) activity was observed using a leukocyte acid phosphatase stain-
ing kit (Sigma). After its development, the slides were dehydrated in a
series of ethanol and xylene and subsequently cover-slipped with
Permount mounting media.
For TUNEL staining, sections were incubated in proteinase K buffer
(20 μg/mL in 10 mM Tris pH 7.5), applied to a TUNEL reaction mixture
(In Situ Cell Death Detection Kit, Roche), and mounted with DAPI
mounting medium (Vector Laboratories). Slides were viewed under
an epiﬂuorescence microscope.
Immunohistochemistry
Tissue sections were deparafﬁnized following standard procedures.
Endogenous peroxidase activity was quenched by 3% hydrogen perox-
ide for 5 min, and then washed in PBS. Slides were blocked with 5%
goat serum (Vector S-1000) for 1 h at room temperature. The appropri-
ate primary antibody was added and incubated overnight at 4 °C, then
washed in PBS. Samples were incubated with appropriate biotinylated
secondary antibodies (Vector BA-x) for 30 min, then washed in PBS.
An avidin/biotinylated enzyme complex (Kit ABC Peroxidase Standard
Vectastain PK-4000) was added and incubated for 30 min and a DAB
substrate kit (Kit Vector Peroxidase substrate DAB SK-4100) was used
to develop the color reaction. Antibodies used include proliferating
cell nuclear antigen (PCNA, Invitrogen) Osteocalcin (Abcam ab93876),
Decorin (NIH LF 113), Osteopontin (NIH LF 175), Fibromodulin (NIH
LF 149), and Procollagen 1(NIH LF42). Each immunostaining reaction
was accompanied by a negative control, where the primary antibody
was not included.
Histomorphometric analyses
Maxillas were collected on postsurgical days 7, 14, 21, and 28 to
quantify the amount of new bone generated in response to the implant.
Allmaxillawere embedded in parafﬁn and sectioned longitudinally. The
0.6-mm implant was represented across ∼20 tissue sections, each of
which was 8 μm thick. Of those 20 sections, we used a minimum of 4
sections to quantify the amount of new bone. All the tissue sections
were stained with aniline blue, which labels osteoid matrix. The sec-
tions were photographed using a Leica digital imaging system at the
same magniﬁcation (×10 objective). The resulting digital images were
analyzedwith Adobe Photoshop CS5 software.We chose a ﬁxed, rectan-
gular region of interest (ROI) that in all images corresponded to 106
pixels. The injury site was always represented inside this ROI by manu-
ally placing the box in the correct position on each image.
The aniline blue-positive pixels were partially automated by using
themagic wand tool set to a color tolerance of 60. This tolerance setting
resulted in highlighted pixels with a range of blue that corresponded
precisely with the histological appearance of osseous tissue in the ani-
line blue-stained sections. Native bone or bone fragments resulting
from the drill injury were manually deselected. The total number of an-
iline blue-positive pixels for each sectionwas recorded. The pixel counts
from individual sections were averaged for each sample, and the differ-
ences within and among treatment groups were calculated based on
these averages.
Statistical analyses
Results are presented as themean ± SEM. Student's t-test was used
to quantify differences described in this article. P ≤ 0.01was considered
to be signiﬁcant.
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Neural crest-derived maxillary bone heals differently than
mesoderm-derived tibial bone
The skeleton contains tissue-resident stem cells that are responsible
for maintaining bone mass [22] and for regenerating new bone follow-
ing injury [23]. By genetic cell lineage labeling studies [24], we
established that adult skeletal stem cells arise from the cranial neural
crest and the mesoderm [23]. Although both stem cell populations
give rise to cartilage and bone, they do not appear to be functionally
equivalent: Neural crest-derived skeletal progenitor cells, which occupy
the ﬁrst branchial arch (Figs. 1A,B) and give rise to the bones and
cartilages of the upper and lower jaws (Figs. 1C–F) exhibit robust
plasticity compared to mesoderm-derived progenitor cells, most
notably in bone grafting assays [25]. Our initial hypothesis was that im-
plant osseointegration in the tibia would be equivalent to implant
osseointegration in the maxilla. Since the two bones are derived from
different embryonic stem cell populations, however, we directly tested
the healing potentials of the tibia compared to the maxilla.
We employed a simple bone defect model in which a 1.0 mm hole
was created in a mesoderm-derived long bone, the tibia, or a neural
crest-derived cranial bone, the maxilla (Figs. 1G,H). The surrounding
cortices were left intact, which minimized micromotion of the injured
bones. There was no obvious difference in the histologic appearance of
the injury sites within the ﬁrst few days of creating the defects
(Fig. 1H and data not shown). By post-injury day 14, however, there
was a clear distinction: tibial injuries were ﬁlled with newly woven
bone that occupied the marrow cavity and bridged the defect (Fig. 1I).Fig. 1. Robust bone repair and implant osseointegration in the tibia compared to themaxilla. (A
crest cells of the ﬁrst branchial arch, (B) that later develop into the maxilla and the mandibl
(D) Permanently labeled LacZ + cranial neural crest cells are found within the ﬁrst branchial a
manently marked for their cranial neural crest origin. (G) Micro-CT image of 0.8 mm skeletal d
through a 0.8 mm tibial defect following injury, stainedwith aniline blue. (I) Representative tiss
The dark blue color denotes collagen-richmatrix in the defect site. (J) Representative section on
0.6 mmmaxillary defect on post-surgery day 14, stainedwith aniline blue. The dark blue color
on post-surgery day 28. MAX, maxilla; MN, mandible. Scale bars: (D–F), 100 μm; (H–L) 100 μmIn contrast, a similar injury in the maxilla was ﬁlled with a ﬁbrous con-
nective tissue (Fig. 1J). Even if we reduced the diameter of themaxillary
defects (compare 1.0 mm in the tibia with 0.5 in themaxilla), the max-
illary injuries did not heal by day 14.
Aremaxillary injuries just slower to heal than tibial injuries?We ex-
amined the injury sites on day 28 and found that the tibial injuries had
completely healed by bony bridging (Fig. 1J), whereas maxillary injury
sites remained ﬁlled with connective/ﬁbrous tissue (Fig. 1L). Therefore,
in addition to their distinct embryonic origins, and a measurable osteo-
genic capacity of bone grafts derived from the two skeletal elements,
craniofacial and long bones have different rates of healing.We reasoned
that this difference would likely manifest as a change in the rate or ex-
tent of implant osseointegration.Establishing an oral implant procedure in mice
Our primary interest is in addressing failures in oral implant
osseointegration. Given the different healing potentials of long bones
and craniofacial bones, we opted to develop an oral implant model sys-
tem that would afford us with the ability to rigorously assess the pro-
gram of oral implant osseointegration.
We ﬁrst carried out a series of experiments in which implants were
placed in the tibia. The surgical procedure, the osseointegration re-
sponse, and the molecular and cellular characteristics of this process
have been documented elsewhere [6,11,14,15,17,26,27]. Here, we
show that new bone, originating from the tibial marrow cavity, is ﬁrst
evident on post-surgical day 5 (Supplemental Fig. 1A). The peri-
implant bone is osseointegrated by day 7 (Supplemental Fig. 1B), and) Scanning electronmicrograph of embryonic head; the red region indicates cranial neural
e. (C) The cranial neural crest cells of Wnt1Cre:R26RLacZ mice are permanently labeled.
rch along with (E) many dental tissues. (F) Mature osteocytes of the maxilla are also per-
efect created in mesoderm-derived long bone, the tibia. (H) Representative tissue section
ue section through a 0.8 mm tibial defect on post-surgery day 14, stainedwith aniline blue.
post-surgery day 28 from the tibia implant site. (K) Representative tissue section through a
indicates the collagen-richmatrix of the bone. (L) Aniline blue stain of themaxillary defect
.
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mental Fig. 1C–E).
We compared osseointegration in the tibia with osseointegration in
themaxilla. Maxillary injuries were created immediately anterior to the
ﬁrst molar, along the alveolar crest in the edentulous space. After anes-
thesia, the oral cavity was rinsed with povidone–iodine solution
(Fig. 2A) and a full thickness crestal incision was performed (Fig. 2B).
The ﬂap was raised and the alveolar bone was accessed (Fig. 2C). In an
attempt to reduce trauma to the alveolar bone, a pilot hole was ﬁrst cre-
ated using a 0.3 mmdrill, followed by a 0.45 mmdrill (Fig. 2D). The im-
plant (0.6 mm; Fig. 2E) was subsequently screwed into place (Fig. 2F).
The gingival tissue was sutured in place, effectively enclosing the im-
plant (Fig. 2G). The position of the implant was anterior to the ﬁrst
molar, along the edentulous ridge, perforating the sinus in all cases
(Fig. 2H). After 14 days, the enclosed implant could be visualized
through the tissue (Fig. 2I). Thus, the procedure used to place a murine
oral implant was very similar to the procedure used for humans.
Murine oral implants undergo osseointegration
We ﬁrst evaluated murine implants using histological analyses and
found that within 7 days, there was evidence of bone formation in the
peri-implant space (Fig. 3A). Upon close examination, the new bone
appeared as an extension of the periosteal surfaces of the native maxil-
lary bone (Fig. 3A′,A″). Fibroblasts also occupied the space between the
cut edge of the bone and the implant surface (Fig. 3A′,A″). On day 14,
more new bone was in contact with the implant surface (Fig. 3B, B′Fig. 2. An oral implant model in mice. (A) Pre-operative photograph of the alveolar crest, ant
intrasulcular incision extends from the lingual surface of themaxillary ﬁrst molar anteriorly, to t
bone. (D) A 0.45 mm hole is prepared on the crest, 1.5 mm anterior of the ﬁrst maxillar
manually, followed by careful rinsing. (G)Wounds are closed with non-absorbable single interr
to the dentition and bones of the skull. (I) Soft tissue covered the healing implant days post-surg
(H) 500 μm.and E). The new osteoid matrix was ﬁlled with vascular spaces
(Fig. 3B″) and at this point the implant was clearly osseointegrated.
The maximum amount of osseointegration was achieved by day 21
(Fig. 3E). Of 23 implants placed, 21 had primary stability and by histo-
logic assessment, 17 achieved osseointegration (a 74% success rate).Murine peri-implant tissue responses are similar to large animal responses
Weevaluated the peri-implant tissue reaction to the surgery and im-
plant placement, and focused on samples harvested on day 14, when
implants had osseointegrated. The peri-implant mucosa appeared
healthy and devoid of inﬂammatory cells (Fig. 4A). A junctional epithe-
lium, composed of non-keratinized, invaginating epithelium had
formed around the neck of a non-enclosed implant (Fig. 4A). The con-
nective tissue attachment was well organized and was in direct contact
with the implant surface (Fig. 4A). In regions closer to the native bone,
new osteoid matrix was forming adjacent to the maxillary periosteum
(arrows, Fig. 4A).
In mice, most implants projected through the maxillary bone into
the olfactory epithelium (e.g., Fig. 3). Murine olfactory tissue, which is
considerably larger in rodents, occupies the position of the nasal fossae
in humans. We evaluated how these tissues responded to the implant.
Fibroblasts had inﬁltrated the glandular olfactory epithelium and ad-
hered to the implant without evidence of inﬂammation (Fig. 4B). In
other cases, new bone formationwas detectable in the ﬁbrous tissue at-
tached to the implant surface (Fig. 4B′).erior to the maxillary ﬁrst molar; black dotted line indicates incision placement. (B) The
he crest of the edentulous space. (C) A full-thickness ﬂap is elevated to expose the alveolar
y molar. (E) The 0.6 mm diameter titanium alloy implant. (F) The implant is placed
upted sutures. (H) Skeletal preparation showing location of themaxillary implant relative
ery.M1,maxillaﬁrstmolar; ab, alveolar bone. Scale bars: (A–D,G, I) 600 μm; (E) 2500 μm;
Fig. 3. Chronology of implant osseointegration in the oral cavity. (A) Representative sagittal tissue section through a maxilla implant site on post-surgery day 7, stained with aniline blue.
The blue color denotes collagen-rich matrix in the defect site. (A′ and A″) High magniﬁcation images of the bone in contact with the implant; white dotted lines outline original bone.
(B)Maxilla implant site on post-surgery day 14. (B′ and B″) Highmagniﬁcation image of the bone in contactwith the implant. (C) Representative sagittal tissue section throughamaxillary
implant. (C′ and C″) High magniﬁcation images on post-surgery day 21. (D) Representative sagittal tissue section through a maxillary implant site on post-surgery day 28, stained with
aniline blue. (D′ and D″) High magniﬁcation image of the bone in contact with the implant. (E) The amount of new bone on post-surgery days 7, 14, 21, and 28 was quantiﬁed using
histomorphometric measurements. Scale bars: (A–D) 200 μm; (A′–D″) 50 μm. Results are presented as the mean ± SEM. P ≤ 0.01 was considered to be signiﬁcant.
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We also analyzed cell viability in the maxillary bone. Using DAPI to
detect cell nuclei and DIC to illustrate the osteocyte lacunae, we noted
areas of extensive cell death in the cortical bone adjacent to the implant
(dotted yellow line, Fig. 4C). The empty lacunae were exclusively found
near the cut edge of themaxillary bone (dotted yellow line, Fig. 4C) and
along the alveolar ridge where the ﬂap was raised during the surgery
(Fig. 4C′). This same DAPI staining indicated abundant new cells on
the (unperturbed) nasal surface of the bone, along the new bone in con-
tactwith the implant surface, and along the periosteum(Fig. 4C,C′). Thus,
the observed changes in peri-implant tissues are remarkably similar to
the mucosal responses observed in large animals [28]. Furthermore,Fig. 4. Peri-implant tissue responses to the implant. (A) Representative sagittal tissue section t
zation of the peri-implantmucosa into three zones; black dotted line indicates tissue–implant in
representative sagittal tissue sections through amaxillary implant site on post-surgery day 14, s
presence of new bone within the ﬁbrous component of the tissue. (C and C′) Representative sa
DAPI; blue indicates cell nuclei. Yellow dotted regions indicate areas of cell death. Scale bars: (the results demonstrate how the standard surgical procedure of implant
placement affects cell viability in the native bone.Newly deposited peri-implant bone is distinct from lamellar bone of the
intact cortex
We were particularly interested in the impact of the osteotomy on
the viability of osteocytes in themaxillary bone, because this has impli-
cations for long-term bone regeneration and bone remodeling at the
site of implant placement. Using samples from day 14, we ﬁrst distin-
guished between mature osteocytes of the maxillary bone (dotted
line, Figs. 5A,B) and new osteoid matrix: Mature maxillary bone had a
lamellar organization whereas the new bone was characterized by ahrough a maxilla implant site on post-surgery day 14, stained with Pentachrome. Organi-
terface.White arrows point to periosteal response. (B and B′)Highmagniﬁcation images of
tainedwith Pentachrome. Note the olfactory tissue adjacent to the implant surface and the
gittal tissue sections through a maxillary implant site on post-surgery day 14, stained with
A) 200 μm; (B–B′) 50 μm; (C–C′) 200 μm.
Fig. 5. Cellular and molecular analyses of oral implant osseointegration. (A and B) Representative sagittal tissue section through a maxillary implant site on post-surgery day 14, stained
with Pentachrome; dotted line indicates native bone and arrows indicate new bone. (C and D) aniline blue stain, the dark blue color denotes collagen in the osteoid tissue. (E and F)
Picrosirius red stain, observed with polarized light; the red color denotes the orientation of the collagen. (G and H) Alkaline phosphatase (ALP) activity is detectable in the newly miner-
alizing bone matrix. (I and J) Tartrate resistance acid phosphatase (TRAP) staining is evident around newly formed bone. (K) TUNEL staining and DAPI, observed with ﬂuorescent light,
where the blue color denotes nuclei of the cells and green color denotes cells undergoing apoptosis. (L) Representative sagittal tissue section of themaxillary implant site on post-surgery
day 14 immunostained for immunostained for Proliferating Cell Nuclear Antigen (PCNA); arrows indicate positive stain. (M) Representative sagittal tissue section of themaxillary implant
site on post-surgery day 14, immunostained for Osteocalcin. (N) Representative sagittal tissue section of themaxillary implant site on post-surgery day 14, immunostained for Osteopon-
tin. (O) Representative sagittal tissue section of the front maxilla implant site on post-surgery day 14 immunostained for Pro-Collagen 1. (P) Representative sagittal tissue section of the
front maxillary implant site on post-surgery day 14, immunostained for Decorin. (Q) Representative sagittal tissue sections from the front maxillary implant site on post-surgery day 14,
immunostained for ﬁbromodulin. Scale bars: (A–K) 100 μm; (L–Q) 25 μm.
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ﬁrmed the lamellar organization of the maxillary bone (white dotted
line, Figs. 5C,D) and the areas of new bone formation (arrows, Figs. 5C,
D). Polarized light and Picrosirius red staining further demarcated the
linear organization of the native bone (dotted line, Figs. 5E,F) from thecrosshatched pattern seen in the new osteoid matrix (arrows, Figs. 5E,
F). Thus, the structure of the new bone was woven in comparison to
the lamellar organization of intact bone. We next evaluated the extent
to which bone remodeling associated with implant placement affected
these two osteoid matrices.
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Using alkaline phosphatase (ALP) activity to identify newlymineral-
izing bonematrix [29,30]we found only the newbone exhibitedALP ac-
tivity; native bone showed no evidence of ALP activity (dotted line
indicates native bone, arrows indicate ALP activity in Figs. 5G,H).
The activity of osteoclasts, as measured by tartrate resistance acid
phosphatase (TRAP) activity [31], was primarily evident on the remod-
eling surfaces of the new osteoid matrix, on both nasal and oral sides of
the bone (Figs. 5I,J). TRAP activity was completely absent from the na-
tive maxillary cortex, indicating a very low rate of bone turnover.
TUNEL activity was used to identify cells undergoing apoptosis [32].
TUNEL activity was minimal along the implant surface on day 14, in
keeping with the deposition of new bone here; instead, TUNEL+ve
cells were found in areas of the native lamellar bone (Fig. 5K), indicating
osteocyte cell death in this locale. We used immunostaining for pro-
liferating cell nuclear antigen (Fig. 5J) to conﬁrm that cells continued
to proliferate in the peri-implant space and in the lacunae (Fig. 5L). Im-
munostaining for Osteocalcin (Fig. 5M), Osteopontin (Fig. 5N), and Pro-
collagen type I (Fig. 5O) veriﬁed that cells were actively differentiating
into osteoblasts in the peri-implant space, and in the periosteum adja-
cent to the implant. Decorin (Fig. 5P) and Fibromodulin (Fig. 5Q), both
markers of ﬁbroblastic cells, were not expressed in the gap-interface,
thus conﬁrming that bone, and not ﬁbrous tissue, formed in the peri-
implant space.
Discussion
Maxillary healing is more challenging than long bone healing
Many of our assumptions concerning oral implant osseointegration
are extrapolated from experimental models studying skeletal tissue re-
pair in long bones [33,34]. We avoided this presupposition by directly
studying oral implant osseointegration in an oral bone, the maxilla.
First, we showed that in comparison to long bone injuries, craniofacial
bones are derived from cranial neural crest (Fig. 1). Second, we ﬁnd
that injuries to craniofacial bones tended to healmore slowly than anal-
ogous injuries to the tibia (Fig. 1). The reasons for this are not obvious
but there are a number of other features that undoubtedly contribute
to the difference in healing potential: for example, the marrow space
in the tibia contains abundant numbers of osteoprogenitor cells, a ro-
bust blood supply, and stem cell niche signals [35,36], all of which are
essential for new bone formation. The maxillary bone, however, has lit-
tle or no marrow space and presumably lacks the stem cell populations
that reside in the marrow cavity. The mechanical environment is also
different between longbones and craniofacial bones, and physical forces
play an important role in implant osseointegration [14]. However, char-
acterizing the relevant mechanical forces, and their relative impact on
healing potential is beyond the scope of this paper.Whatever the causal
factors are, our study demonstrated that even when small injuries are
made in the maxilla, they fail to heal with new bone (Fig. 1), and thus
represent a “critical size” skeletal defect (e.g., see [37,38]). Collectively,
these data strongly suggest that in order to understand and improve
the process of oral implant osseointegration, the most relevant studies
will take this healing potential difference into account.
The peri-implant mucosal response is similar in mice and large animals
Establishing contact between themucosa and the implant creates an
effective barrier against bacterial invasion into the soft tissues, and
therefore protects the bone. In ourmousemodel, we observed three tis-
sue compartments in contact with the implant: a gingival epithelial
zone, a connective tissue zone, and a periosteal zone (Fig. 4). These
same zones have been described in large animal models [28], and thus
this murine model recapitulates this important feature of implant
biology.This murine model also can be used for studying how surface and
shape modiﬁcations to the neck of the implant, or the connector, affect
the adhesion of the connective tissue ﬁbroblasts in vivo. Similar studies
have been conducted in dogs [39], but mice offer a wide array of molec-
ular and cellular toolswithwhich to analyze the cellular and tissue-level
responses that are unavailable for canine species. Other groups [19–21]
have used rodents with similar maxillary models, where implant is
placed in a ridge defectmodel where a tooth never existed. Collectively,
these studies and ours show that oral implant osseointegration is
achievable in a rodent model.
The chronology of osseointegration is similar in mice and large animals
The surgical procedure used in mice parallels the general procedure
used for implant placement in humans [40,41], but there are two gener-
al features that differ between humans and the mouse model that may
have a bearing on osseointegration. First, there is a difference in skeletal
architecture in themaxilla: inmice, there is a reduced amount of trabec-
ular (cancellous) bone and in place of this trabecular framework is
cortical bone (Fig. 3). Cortical bone provides primary stability for
implants [42] whereas the function(s) of the trabecular bone in
osseointegration is unknown. The marrow that occupies the trabecular
bone in humansmay be the source of growth factors that stimulate new
bone deposition, which in turn might inﬂuence the extent of osseo-
integration, but this point remains conjecture. A second point dis-
tinguishing osseointegration in mice from that in humans is the
rapidity with which implant osseointegration occurs in mice. In
humans, osseointegration is thought to take at least 6–8 weeks [2]. In
our mouse model, implant osseointegration is evident by day 14
(Fig. 3). The similarities between this mouse model and large animal
models of osseointegration allowed us to explore themolecular and cel-
lular characteristics that affect implant osseointegration.
The periosteum is the likely source of osteogenic stem cells that give rise to
peri-implant bone
Abundant new bone forms around maxillary implants (Fig. 3) but
the source(s) of the osteoblasts are not currently known. Because
there is no obviousmarrow space in themurinemaxillae, we speculated
that the newbone arises from the nasal and oral periostea of themaxilla
(Fig. 5A). Implant bed preparation injures the periosteum, and the typ-
ical response to such an injury is cell proliferation in the ﬁbrous layer
[14]. In amechanically neutral environment, these proliferating skeletal
progenitor cells differentiate into osteoblasts and give rise to new bone
[23]. Consequently, all efforts should be made to preserve the perioste-
um at the site of implant placement because in this tissue resides the
skeletal stem cells that generate the new bone [22].
Implant placement destroys osteocytes in the cortical bone
A ﬁnding from these analyses that has direct clinical relevance was
the extensive cell death observed in the alveolar bone in response to
the implant surgery, and the cell death in the crest of the cortical bone
in response to the raised ﬂap (Figs. 4,5). In both cases, only themineral-
ized matrix of the dead bone is retained and it provides some mechan-
ical support for the implant. The dead bonemust eventually be resorbed
by osteoclasts, and replaced by new bone (e.g., see [43]). This process of
cortical bone remodeling does not take place immediately (Fig. 2) but
rather, appears to be part of the normal bone turnover process. In
humans, this bone turnover is measured in years [44]; in mice, this
bone turnover is measured in months. In this window of time, between
TRAP-mediated bone resorption and ALP+ve new bone formation, the
implant may lose some of its stability [45]. The same cycle of bone re-
sorption and bone formation likely occurs in humans, and a key consid-
eration for the timing of prosthetic loading will undoubtedly be this
phase of peri-implant bone turnover.
184 S. Mouraret et al. / Bone 58 (2014) 177–184Towards predicting successful implant osseointegration
Caninemodels of oral implant osseointegration have been extensive-
ly employed in the past, and have a signiﬁcant advantage because human
size implants can be directly tested in a dogmodel. There are a number of
serious limitations, however, including the cost associated with a large
study in canines and the complete lack of genetic, molecular and cellular
tools for analyses. Once the small size of themouse is overcome, there are
a number of advantages to this model of oral implant osseointegration.
Our long-term objective is to be able to predict implant success versus
failure by careful analysis of the steps leading up to new bone formation
around implants. A step towards achieving that goal is the development
of a mouse model whereby the program of implant osseointegration can
be rigorously dissected. Future studies will focus on the basic biology of
implant failure, as well as new therapeutic strategies to re-program ﬁ-
brous tissue around a failed implant into the bone.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bone.2013.07.021.
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